Mastocytosis and related disorders

Area of Science:

• Hematology
• Oncology
• Pathology

Background:

• Mastocytosis is a diverse group of disorders marked by excessive mast cell accumulation.
• Subtypes are classified by organ involvement, lab results, and organ damage severity.
• Cutaneous mastocytosis affects the skin, common in children, while systemic mastocytosis impacts adults with extracutaneous organ involvement.

Purpose of the Study:

• To review mastocytosis subtypes, diagnostic criteria, and related conditions.
• To discuss key laboratory findings and morphological characteristics of mast cells.
• To explore the utility of CD30 expression in differentiating systemic mastocytosis subtypes.

Main Methods:

• Review of existing literature on mastocytosis and related disorders.
• Analysis of diagnostic criteria for cutaneous and systemic mastocytosis.
• Examination of pathological and molecular findings, including mast cell morphology, CD expression, and KIT mutations.

Main Results:

• Systemic mastocytosis features dense mast cell aggregates in bone marrow or other organs.
• Atypical mast cell morphology, aberrant CD2/CD25 expression, elevated serum tryptase, and KIT D816V mutations are common.
• CD30 expression is a potential marker differentiating aggressive systemic mastocytosis and mast cell leukemia from indolent forms.

Conclusions:

• Mastocytosis classification depends on clinical and laboratory features.
• Myelomastocytic overlap syndromes present diagnostic challenges due to similarities with systemic mastocytosis.
• Further research into diagnostic markers like CD30 is crucial for accurate subtyping and management.